AI Detects Carpal Tunnel in Ultrasound Videos at Aster CMI Neurology

India Pharma Outlook Team | Thursday, 08 February 2024

 India Pharma Outlook Team

Aster CMI Hospital is leading the way in AI support for healthcare with innovations that support healthcare professionals in various aspects of care, including the analysis of large amounts of data that enables faster and more accurate diagnosis of disease and the development of new treatment options. Keep track of what's important across all disciplines.

AI Carpal tunnel syndrome (CTS) is one of the technologies developed in neurology that is poised to change near ultrasound. This technology is good for reboots, checks and screens. Medical innovation can be improved by identifying the median nerve on ultrasound images and detecting CTS with high accuracy (95%). Artificial intelligence tools represent a revolutionary step towards accuracy and efficiency in diagnosing CTS and ushering in a new era of healthcare.

"As the healthcare landscape evolves from diagnostic to predictive models, AI will emerge as a catalyst for this transformative journey. Our collaboration with government agencies demonstrates our commitment to ethical AI practices, compliance with legal regulations and the highest privacy and data security standards. This new technology device represents a new beginning in healthcare," said Dr. Nitish Shetty, CEO of Aster DM Healthcare.

Dr Lokesh Bathala, Senior Consultant, Neurology, said: "Health. We offer a range of services, including diagnostics. We are pushing the boundaries of medicine by designing AI tools that will revolutionize the future of treatment and prevention, potentially preventing complications in the long term and improving the quality of life. In addition, it can reduce patient pain and anxiety by reducing the need for repeated tests and invasive procedures. AI tools greatly reduce the decision time, but it is important to remember that the doctor makes the final diagnosis.

© 2024 India Pharma Outlook. All Rights Reserved.